CB Pharma Acquisition Priced, Nasdaq: CNLMU

Biotech-focused blank check company backed by Coronado Biosciences.

Industry: SPAC

Latest Trade: $10.30 +10.29 (+102900.0%)

First Day Return: 0.0%

Return from IPO: -99.9%

Industry: SPAC

Biotech-focused blank check company backed by Coronado Biosciences.
more less
IPO News for CB Pharma Acquisition
more
IPO Data
IPO File Date 10/23/2014
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 4.0
Deal Size ($mm) $40
IPO Data
IPO Date 12/12/2014
Offer Price $10.00
Price Range $10.00 - $10.00
Offer Shares (mm) 4.0
Deal Size ($mm) $40
Underwriters
more
Company Data
Headquarters Burlington, MA
Founded 2014
Employees
Website www.coronadobiosciences.com